Acupuncture at the Sphenopalatine Ganglion in the Treatment of Moderate-to-severe Seasonal Allergic Rhinitis

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Seasonal Allergic Rhinitis
Interventions
OTHER

Acupuncture group

Sterile single-use stainless steel needles (size 0.35 mm × 55 mm) (YiDaiFu brand, Suzhou Tianyi Acupuncture Instrument Co., Ltd., Suzhou, China) will be utilized. Participants in lateral position, the acupoints area will be sterilized with 75% alcohol. To stimulate SPG, the needles will be inserted in the medial superior anterior direction to a depth of approximately 55 mm33 until the participants report a special sensation radiating toward the nose or the upper teeth. After that, the needle will be withdrew slightly. The needles will be retained for 30 minutes after three stimulation. Rescue medication are permitted when participants feel that their symptoms are intolerable.

OTHER

Placebo acupuncture group

The acupuncture procedure will be similar to that of the acupuncture group. After sterilizing the skin, the 0.35 × 25 mm disposable needle will be vertically inserted at SPG acupoint about 3-5 mm. No needle manipulation will be conducted to avoid the deqi response. Rescue medication are permitted when participants feel that their symptoms are intolerable.

OTHER

Rescue medication group

Participants in the rescue medication group do not receive acupuncture treatment during the study period. They will be only allowed to use rescue medication. They have the option of 4 weeks (up to 8 sessions) of acupuncture free of charge at the end of the follow-up period.

Trial Locations (1)

Unknown

RECRUITING

No.731 Hospital of China Aerospace Science and Industry Corporation, Beijing

All Listed Sponsors
collaborator

Aerospace 731 Hospital

OTHER

lead

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

OTHER